Xiaojing Liu Selected Research

4,6- dimorpholino- N- (4- nitrophenyl)- 1,3,5- triazin- 2- amine

9/2022

Celastrol inhibits LL37-induced rosacea by inhibiting Ca2+/CaMKII-mTOR-NF-κB activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaojing Liu Research Topics

Disease

48	Neoplasms (Cancer) 07/2022 - 06/2006
23	Inflammation (Inflammations) 09/2022 - 09/2002
11	Fibrosis (Cirrhosis) 01/2022 - 04/2002
10	Infections 06/2022 - 01/2014
7	Acne Vulgaris 09/2022 - 01/2017
6	Pain (Aches) 09/2022 - 01/2017
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 10/2015
6	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2015
6	Atherosclerosis 01/2022 - 02/2005
6	Cardiomegaly (Heart Hypertrophy) 01/2021 - 06/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2008
6	Hypertrophy 01/2019 - 04/2014
5	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 02/2013
5	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2012
4	Actinic Keratosis 09/2022 - 12/2018
4	Colitis 04/2022 - 10/2017
4	Sepsis (Septicemia) 04/2022 - 01/2017
4	Hypoxia (Hypoxemia) 03/2022 - 08/2010
4	Carcinogenesis 03/2022 - 01/2018
4	Melanoma (Melanoma, Malignant) 09/2020 - 10/2016
4	Liver Cirrhosis (Hepatic Cirrhosis) 08/2020 - 01/2015
4	Heart Failure 09/2019 - 04/2005
4	Myocardial Infarction 02/2017 - 04/2005
3	Erythema 09/2022 - 01/2017
3	Hypothyroidism 03/2022 - 01/2016
3	Edema (Dropsy) 03/2022 - 08/2019
3	Hepatitis B 01/2022 - 10/2019
3	Carcinoma (Carcinomatosis) 12/2021 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2017
3	Coronary Disease (Coronary Heart Disease) 10/2020 - 04/2002
3	Asthma (Bronchial Asthma) 01/2019 - 09/2002
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 11/2016
3	Colonic Neoplasms (Colon Cancer) 12/2018 - 01/2014
3	Acute Lung Injury 01/2017 - 07/2008
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2012 - 05/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022 - 01/2012
2	Rosacea (Acne Rosacea) 09/2022 - 09/2022
2	Atrophy 09/2022 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 07/2022 - 01/2017
2	End Stage Liver Disease 04/2022 - 01/2022
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 06/2019
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 09/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 04/2002
2	Liver Diseases (Liver Disease) 01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 04/2022 - 04/2002
15	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 04/2002
12	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022 - 01/2017
11	EnzymesIBA 10/2020 - 05/2013
10	CytokinesIBA 09/2022 - 07/2008
9	AcidsIBA 09/2022 - 01/2017
9	Messenger RNA (mRNA)IBA 01/2022 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2021 - 11/2018
6	Small Interfering RNA (siRNA)IBA 08/2018 - 01/2007
5	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2021
5	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2015
5	Long Noncoding RNAIBA 12/2021 - 10/2018
5	Biological ProductsIBA 10/2021 - 01/2021
4	Glutamine (L-Glutamine)FDA Link 07/2022 - 02/2015
4	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 01/2018
4	NucleotidesIBA 01/2022 - 11/2014
4	ChitosanIBA 01/2021 - 02/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 04/2009
4	LipopolysaccharidesIBA 10/2017 - 07/2008
3	Dextran SulfateIBA 04/2022 - 12/2019
3	Amino Acids FDA Link 03/2022 - 03/2016
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 08/2010
3	LipidsIBA 12/2021 - 02/2005
3	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 04/2016
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 11/2012
3	Galectins (Galectin)IBA 01/2021 - 11/2018
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 11/2018
3	Nicotinamide PhosphoribosyltransferaseIBA 10/2020 - 04/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2020 - 01/2018
3	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2020 - 04/2002
3	IsotopesIBA 01/2019 - 12/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2007
3	Histones (Histone)IBA 01/2019 - 01/2015
3	Fluorouracil (Carac)FDA LinkGeneric 12/2018 - 01/2016
3	AntioxidantsIBA 10/2017 - 01/2010
3	CarbonIBA 11/2016 - 11/2014
3	Glycoproteins (Glycoprotein)IBA 03/2016 - 05/2003
3	Peptides (Polypeptides)IBA 03/2016 - 01/2014
2	CalciumIBA 09/2022 - 11/2019
2	Indicators and Reagents (Reagents)IBA 09/2022 - 01/2015
2	Environmental Pollutants (Pollutants, Environmental)IBA 06/2022 - 03/2022
2	CholesterolIBA 04/2022 - 08/2020
2	Hepatitis B e AntigensIBA 04/2022 - 01/2021
2	Alkaline PhosphataseIBA 04/2022 - 11/2019
2	AntibodiesIBA 03/2022 - 10/2019
2	AntigensIBA 01/2022 - 01/2019

Therapy/Procedure

29	Therapeutics 10/2022 - 06/2006
13	Photochemotherapy (Photodynamic Therapy) 09/2022 - 01/2017
7	Immunotherapy 01/2022 - 09/2015
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
3	Ligation 10/2021 - 06/2009
3	Transplantation 01/2018 - 04/2005
2	Lasers (Laser) 09/2022 - 03/2022
2	Photothermal Therapy 01/2022 - 01/2021